TS
Travis Steed Barclays Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
Insulet
PODD
$23.8B
| $337.94 | $300 |
11%
downside
| Overweight |
25 May ‘21
4 years ago |
|
27
CONMED
CNMD
$1.67B
| $54.05 | $175 |
224%
upside
| Overweight |
25 May ‘21
4 years ago |
|
28
Stryker
SYK
$149B
| $388.79 | $280 |
28%
downside
| Underweight |
25 May ‘21
4 years ago |
|
29
Tandem Diabetes Care
TNDM
$864M
| $12.79 | $90 |
604%
upside
| Underweight |
25 May ‘21
4 years ago |
|
30
DexCom
DXCM
$29.8B
| $76 | $125 |
64%
upside
| Buy |
17 Jun ‘20
5 years ago |
|
31
Integra LifeSciences
IART
$1.21B
| $15.47 | $54 |
249%
upside
| Neutral |
1 Nov ‘18
6 years ago |
|
32
Zimmer Biomet
ZBH
$20.7B
| $104.26 | $145.63 |
40%
upside
| Overweight |
30 Jul ‘18
7 years ago |
|